NEUPOGEN XL Trademark

Trademark Overview

On Thursday, October 5, 2006, a trademark application was filed for NEUPOGEN XL with the United States Patent and Trademark Office. The USPTO has given the NEUPOGEN XL trademark a serial number of 77014795. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 24, 2010. This trademark is owned by Amgen Inc.. The NEUPOGEN XL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for stimulating white blood cell production
neupogen xl

General Information

Serial Number77014795
Word MarkNEUPOGEN XL
Filing DateThursday, October 5, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 24, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 30, 2007

Trademark Statements

Disclaimer with Predetermined TextXL
Goods and ServicesPharmaceutical preparations for stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 10, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Monday, May 24, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 24, 2010ABANDONMENT - NO USE STATEMENT FILED
Monday, September 28, 2009EXTENSION 5 GRANTED
Thursday, September 24, 2009EXTENSION 5 FILED
Thursday, September 24, 2009TEAS EXTENSION RECEIVED
Monday, April 6, 2009EXTENSION 4 GRANTED
Monday, March 23, 2009EXTENSION 4 FILED
Monday, April 6, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 23, 2009TEAS EXTENSION RECEIVED
Thursday, September 18, 2008EXTENSION 3 GRANTED
Monday, September 15, 2008EXTENSION 3 FILED
Thursday, September 18, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 15, 2008TEAS EXTENSION RECEIVED
Thursday, April 17, 2008EXTENSION 2 GRANTED
Monday, March 31, 2008EXTENSION 2 FILED
Monday, March 31, 2008TEAS EXTENSION RECEIVED
Monday, September 24, 2007EXTENSION 1 GRANTED
Tuesday, September 11, 2007EXTENSION 1 FILED
Tuesday, September 11, 2007TEAS EXTENSION RECEIVED
Tuesday, April 24, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 30, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 10, 2007NOTICE OF PUBLICATION
Wednesday, December 6, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 6, 2006ASSIGNED TO LIE
Saturday, November 18, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 9, 2006EXAMINER'S AMENDMENT ENTERED
Wednesday, November 8, 2006EXAMINERS AMENDMENT E-MAILED
Wednesday, November 8, 2006EXAMINERS AMENDMENT -WRITTEN
Friday, November 3, 2006ASSIGNED TO EXAMINER
Tuesday, October 10, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

neupogen cell production blood white preparations stimulating pharmaceutical